Telmisartan, an FDA-approved blood pressure drug, could boost a certain cancer treatment's effectiveness against tumors, a ...

In A Nutshell A common blood pressure drug, telmisartan, boosted the effectiveness of a cancer drug in lab and mouse studies.

In a new Dartmouth Cancer Center (DCC) study led by clinical researcher Tyler J. Curiel, MD, MPH, FACP, investigators found ...

A large international study of more than 23,000 patients has found that common medicines used to treat high blood pressure and cholesterol, as well as heartburn, may be impacting cancer treatment ...

Most of the oncology drugs that received the FDA’s accelerated approval from 2011 to 2020 had some kind of FDA postmarketing safety action, according to a research letter. Safety actions included ...

Commonly prescribed cardiovascular medications - such as statins, diuretics, and blood pressure drugs - appear to have little or no negative impact on survival among people living with multiple ...

Common diabetes drugs may do more than regulate blood sugar—they could also influence how cancers grow, spread, or slow down. Researchers are now unraveling how these medications affect immune ...